PCM
RXDX

Pentwater Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Pentwater Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,000
Closed -$660K – 118
2022
Q4 		$660K Buy
+6,000
New +$660K 0.01% 72